Evidence map›Paper›PMID 11000217›Full record

ArticleJournal of virology2000

Loss of heterozygosity at the Ink4a/Arf locus facilitates Abelson virus transformation of pre-B cells.

J Mostecki, A Halgren, A Radfar, Z Sachs, J Ravitz, K C Thome, N Rosenberg

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

J MosteckiDepartments of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
A Halgren
A Radfar
Z Sachs
J Ravitz
K C Thome
N Rosenberg
Institute of Immunology · HR

Funding

RNA TUMOR VIRUS/HEMATOPOIETIC CELLS INTERACTIONSR01CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1985 to 2007
$2.6M
RNA TUMOR VIRUS-HEMATOPOIETIC CELL INTERACTIONR37CA033771 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1993 to 1997
–
NCI NIH HHS CA 33771NCI NIH HHS R01 CA033771
6 · The paper itself

Abstract

In many tumor systems, analysis of cells for loss of heterozygosity (LOH) has helped to clarify the role of tumor suppressor genes in oncogenesis. Two important tumor suppressor genes, p53 and the Ink4a/Arf locus, play central roles in the multistep process of Abelson murine leukemia virus (Ab-MLV) transformation. p53 and the p53 regulatory protein, p19Arf, are required for the apoptotic crisis that characterizes the progression of primary transformed pre-B cells to fully malignant cell lines. To search for other tumor suppressor genes which may be involved in the Ab-MLV transformation process, we used endogenous proviral markers and simple-sequence length polymorphism analysis to screen Abelson virus-transformed pre-B cells for evidence of LOH. Our survey reinforces the role of the p53-p19 regulatory pathway in transformation; 6 of 58 cell lines tested had lost sequences on mouse chromosome 4, including the Ink4a/Arf locus. Consistent with this pattern, a high frequency of primary pre-B-cell transformants derived from Ink4a/Arf +/- mice became established cell lines. In addition, half of them retained the single copy of the locus when the transformation process was complete. These data demonstrate that a single copy of the Ink4a/Arf locus is not sufficient to fully mediate the effects of these genes on transformation.

Indexed as

Cell Transformation, ViralGenes, Tumor SuppressorLoss of HeterozygosityAbelson murine leukemia virusAnimalsB-LymphocytesCarrier ProteinsChromosome MappingCyclin-Dependent Kinase Inhibitor p16Genes, p53Hematopoietic Stem CellsMiceMice, Inbred BALB CMice, Inbred C57BLMice, Inbred CBACarrier ProteinsCyclin-Dependent Kinase Inhibitor p16

Identifiers

PMID11000217
PMCPMC112377
OpenAlexW2148169855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.